JPH06504995A - 医薬 - Google Patents
医薬Info
- Publication number
- JPH06504995A JPH06504995A JP4503581A JP50358192A JPH06504995A JP H06504995 A JPH06504995 A JP H06504995A JP 4503581 A JP4503581 A JP 4503581A JP 50358192 A JP50358192 A JP 50358192A JP H06504995 A JPH06504995 A JP H06504995A
- Authority
- JP
- Japan
- Prior art keywords
- chloropurine
- amino
- reaction
- guanine
- temac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 10
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical group ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000012320 chlorinating reagent Substances 0.000 claims description 6
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 229960001179 penciclovir Drugs 0.000 claims description 3
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 claims description 2
- 229960004396 famciclovir Drugs 0.000 claims description 2
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- ISTBVJOFZNQWJF-UHFFFAOYSA-N 2-(hydroxyamino)-3,7-dihydropurin-6-one Chemical compound O=C1NC(NO)=NC2=C1NC=N2 ISTBVJOFZNQWJF-UHFFFAOYSA-N 0.000 claims 1
- ZKBQDFAWXLTYKS-UHFFFAOYSA-N 6-Chloro-1H-purine Chemical compound ClC1=NC=NC2=C1NC=N2 ZKBQDFAWXLTYKS-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 230000037452 priming Effects 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000003444 phase transfer catalyst Substances 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 4
- -1 2-amino-6-chloropurine compound Chemical class 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- NIUZJTWSUGSWJI-UHFFFAOYSA-M triethyl(methyl)azanium;chloride Chemical group [Cl-].CC[N+](C)(CC)CC NIUZJTWSUGSWJI-UHFFFAOYSA-M 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 229940127073 nucleoside analogue Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000003884 phenylalkyl group Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
- 1.グアニンまたはその2,9−ジアシル化誘導体を、TEMACの存在下で塩 素化剤と反応させ、その後、必要ならば加水分解により9−アシル基を除去する ことからなる、2−アミノ−6−クロロプリンまたはその2−アシル化誘導体の 製法。
- 2.塩素化剤がオキシ塩化リンである請求項1記載の方法。
- 3.塩素化剤が3〜6モル当量の量にて存在する請求項1または2記載の方法。
- 4.TEMACが1〜2当量の量にて存在する請求項1〜3記載のいずれか1つ の方法。
- 5.反応を溶媒としてのアセトニトリル中で実施する請求項1〜4記載のいずれ か1つの方法。
- 6.本質的に実施例のいずれか1つに記載されている請求項1記載の方法。
- 7.請求項1〜6に記載のいずれか1つの方法により製造される2−アミノ−6 −クロロプリン。
- 8.請求項1に記載の方法により2−アミノ−6−クロロプリンを製造し、その 後、2−アミノ−6−クロロプリンを適当な側鎖先駆体で9−置換し、ついで6 −クロロ部をヒドロキシ(グアニン)または水素(2−アミノプリン)に変換す ることからなる、ペンシクロビル(penciclovir)またはファムシク ロビル(famciclovir)の製法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102127A GB9102127D0 (en) | 1991-01-31 | 1991-01-31 | Pharmaceuticals |
| GB9102127.9 | 1991-01-31 | ||
| PCT/GB1992/000177 WO1992013859A1 (en) | 1991-01-31 | 1992-01-30 | Pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06504995A true JPH06504995A (ja) | 1994-06-09 |
| JP2618578B2 JP2618578B2 (ja) | 1997-06-11 |
Family
ID=10689331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4503581A Expired - Fee Related JP2618578B2 (ja) | 1991-01-31 | 1992-01-30 | 医 薬 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5910589A (ja) |
| EP (1) | EP0569421B1 (ja) |
| JP (1) | JP2618578B2 (ja) |
| KR (1) | KR100213936B1 (ja) |
| AT (1) | ATE154803T1 (ja) |
| AU (1) | AU655002B2 (ja) |
| CA (1) | CA2101640C (ja) |
| DE (1) | DE69220565T2 (ja) |
| DK (1) | DK0569421T3 (ja) |
| ES (1) | ES2104892T3 (ja) |
| GB (1) | GB9102127D0 (ja) |
| GR (1) | GR3023917T3 (ja) |
| HK (1) | HK1007312A1 (ja) |
| IE (1) | IE920294A1 (ja) |
| MX (1) | MX9200398A (ja) |
| NZ (1) | NZ241442A (ja) |
| PT (1) | PT100074B (ja) |
| WO (1) | WO1992013859A1 (ja) |
| ZA (1) | ZA92606B (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9102127D0 (en) * | 1991-01-31 | 1991-03-13 | Smithkline Beecham Plc | Pharmaceuticals |
| CA2076886C (en) * | 1991-11-22 | 2002-06-11 | Masami Igi | Method for production of 2-amino-6-halogenopurine and synthesis intermediate therefor |
| GB9201961D0 (en) * | 1992-01-30 | 1992-03-18 | Smithkline Beecham Plc | Pharmaceuticals |
| DE4231036A1 (de) * | 1992-09-17 | 1994-03-24 | Basf Ag | Verfahren zur Herstellung von 2-Amino-6-halogenpurinen |
| JPH07133276A (ja) * | 1993-09-17 | 1995-05-23 | Jiyuuzen Kagaku Kk | 2−アセチルアミノ−6−クロロプリンの製造方法 |
| WO1996021664A1 (de) * | 1995-01-09 | 1996-07-18 | Lonza Ag | Verfahren zur herstellung von 2-amino-6-chlorpurin und zwischenprodukte dafür |
| CA2189088C (en) * | 1995-11-09 | 2005-09-20 | Masatoshi Sakai | 2-amino-6-chloropurine and method for preparing the same |
| US6419934B1 (en) | 1999-02-24 | 2002-07-16 | Edward L. Tobinick | TNF modulators for treating neurological disorders associated with viral infection |
| DE60220658T2 (de) * | 2001-04-05 | 2008-02-21 | Sumitomo Chemical Co., Ltd. | Verfahren zur produktion von 2,6-dihalogenopurinen |
| WO2007037790A2 (en) * | 2005-06-08 | 2007-04-05 | Elan Corporation, Plc | Modified release famciclovir compositions |
| EP1852435A1 (en) * | 2006-04-12 | 2007-11-07 | SOLMAG S.p.A. | A process for the manufacture of famciclovir using phase-transfer catalysts |
| CN117466895A (zh) * | 2023-10-30 | 2024-01-30 | 江苏八巨药业有限公司 | 一种2-氨基-6-氯嘌呤的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0141927B1 (en) * | 1983-08-18 | 1991-10-30 | Beecham Group Plc | Antiviral guanine derivatives |
| EP0182024B1 (en) * | 1984-09-20 | 1991-04-03 | Beecham Group Plc | Purine derivatives and their pharmaceutical use |
| GB8507606D0 (en) * | 1985-03-23 | 1985-05-01 | Beecham Group Plc | Process |
| GB8916698D0 (en) * | 1989-07-21 | 1989-09-06 | Beecham Group Plc | Novel process |
| DE3941657A1 (de) * | 1989-12-16 | 1991-06-20 | Hoechst Ag | Verfahren zur herstellung von 2-acylamino-6-halogen-purin aus 2,9-diacylguanin |
| GB9102127D0 (en) * | 1991-01-31 | 1991-03-13 | Smithkline Beecham Plc | Pharmaceuticals |
| CA2076886C (en) * | 1991-11-22 | 2002-06-11 | Masami Igi | Method for production of 2-amino-6-halogenopurine and synthesis intermediate therefor |
-
1991
- 1991-01-31 GB GB919102127A patent/GB9102127D0/en active Pending
-
1992
- 1992-01-29 IE IE029492A patent/IE920294A1/en not_active IP Right Cessation
- 1992-01-29 ZA ZA92606A patent/ZA92606B/xx unknown
- 1992-01-29 NZ NZ241442A patent/NZ241442A/en not_active IP Right Cessation
- 1992-01-30 AT AT92903581T patent/ATE154803T1/de not_active IP Right Cessation
- 1992-01-30 AU AU11858/92A patent/AU655002B2/en not_active Ceased
- 1992-01-30 KR KR1019930702265A patent/KR100213936B1/ko not_active Expired - Fee Related
- 1992-01-30 JP JP4503581A patent/JP2618578B2/ja not_active Expired - Fee Related
- 1992-01-30 EP EP92903581A patent/EP0569421B1/en not_active Expired - Lifetime
- 1992-01-30 ES ES92903581T patent/ES2104892T3/es not_active Expired - Lifetime
- 1992-01-30 DK DK92903581.4T patent/DK0569421T3/da active
- 1992-01-30 WO PCT/GB1992/000177 patent/WO1992013859A1/en not_active Ceased
- 1992-01-30 HK HK98106524A patent/HK1007312A1/en not_active IP Right Cessation
- 1992-01-30 PT PT100074A patent/PT100074B/pt not_active IP Right Cessation
- 1992-01-30 DE DE69220565T patent/DE69220565T2/de not_active Expired - Lifetime
- 1992-01-30 US US08/409,490 patent/US5910589A/en not_active Expired - Lifetime
- 1992-01-30 MX MX9200398A patent/MX9200398A/es unknown
- 1992-01-30 CA CA002101640A patent/CA2101640C/en not_active Expired - Lifetime
-
1997
- 1997-06-26 GR GR970401565T patent/GR3023917T3/el unknown
-
1999
- 1999-02-26 US US09/261,609 patent/US6093819A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0569421B1 (en) | 1997-06-25 |
| KR930703320A (ko) | 1993-11-29 |
| GB9102127D0 (en) | 1991-03-13 |
| ZA92606B (en) | 1992-12-30 |
| PT100074A (pt) | 1993-06-30 |
| JP2618578B2 (ja) | 1997-06-11 |
| DK0569421T3 (da) | 1997-09-01 |
| GR3023917T3 (en) | 1997-09-30 |
| AU655002B2 (en) | 1994-12-01 |
| WO1992013859A1 (en) | 1992-08-20 |
| AU1185892A (en) | 1992-09-07 |
| DE69220565T2 (de) | 1997-12-11 |
| US6093819A (en) | 2000-07-25 |
| PT100074B (pt) | 1999-06-30 |
| HK1007312A1 (en) | 1999-04-09 |
| KR100213936B1 (ko) | 1999-08-02 |
| CA2101640C (en) | 2002-07-09 |
| IE920294A1 (en) | 1992-07-29 |
| NZ241442A (en) | 1994-11-25 |
| MX9200398A (es) | 1992-07-01 |
| EP0569421A1 (en) | 1993-11-18 |
| US5910589A (en) | 1999-06-08 |
| DE69220565D1 (de) | 1997-07-31 |
| ES2104892T3 (es) | 1997-10-16 |
| ATE154803T1 (de) | 1997-07-15 |
| CA2101640A1 (en) | 1992-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3670012B2 (ja) | クロロピリミジン中間体 | |
| JPH06504995A (ja) | 医薬 | |
| RU2090566C1 (ru) | Способ получения 9-замещенных производных гуанина | |
| HK1007312B (en) | Process for the preparation of 2-amino-6-chloropurine and derivatives | |
| JPS61227583A (ja) | 新規な化学方法 | |
| AU669874B2 (en) | Preparation of 2-amino-6-chloropurine | |
| JP4531250B2 (ja) | クロロプリン中間体の合成法 | |
| JP2009503034A (ja) | 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法 | |
| JPH08502055A (ja) | 2−アミノ−6−クロロプリンの製造方法 | |
| US5663338A (en) | Process for preparing 2-amino-6-chloropurine | |
| JPH0645620B2 (ja) | キサンチン類のメチル化方法 | |
| HU198179B (en) | Process for producing n-methyl-1-alkylthio-2-nitroethenamine derivatives | |
| JPH07300480A (ja) | 2−アミノ−6−クロロプリン及び2−アシルアミノ−6−クロロプリンの製造のための改良された方法 | |
| JP3179592B2 (ja) | 1−ベンジルヒダントインの製造方法 | |
| JPH05170766A (ja) | 6−クロロプリンの合成方法 | |
| JPH0341466B2 (ja) | ||
| JPH0578358A (ja) | 新規な化合物調整法及び精製法 | |
| JPS582944B2 (ja) | 4(5)−シアイミダゾ−ル−5(4)−カルボキシアミドの製造方法 | |
| JPS6111233B2 (ja) | ||
| JPS5843972A (ja) | ジヒドロキシプロピルテオフイリンの製造方法 | |
| JPH02108673A (ja) | シトシンをアルカリ性溶液から硫酸で沈澱する改良方法 | |
| JPH0390082A (ja) | 光学活性キナゾリノン誘導体のラセミ化方法 | |
| JPH04230383A (ja) | 2−クロロ−1,7−ジヒドロプリン−6−オンの製造方法及びその精製方法 | |
| JPS63246374A (ja) | ピリド〔1,2−a〕ピリミジン化合物の製造法 | |
| JPH03106880A (ja) | 2‐(1‐ピペラジニル)‐8‐エチル‐5,8,‐ジヒドロ‐5‐オキソピリド[2,3‐α]ピリミジン‐6‐カルボン酸三水和物の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080311 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090311 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100311 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110311 Year of fee payment: 14 |
|
| LAPS | Cancellation because of no payment of annual fees |